Showing results (1-10 of 35) with videos related to
Sort By:
Pageof 4
Bioanalysis|June 9, 2023
Application of novel plasma separation filter cards for quantification of nucleoside/nucleotide reverse transcriptase inhibitor di/triphosphates in dried blood spots using LC-MSBeth Thompson, Sujan Dilly-Penchala, Alieu Amara, et al.Therapeutic Drug Monitoring|February 10, 2016
A Validated Method for Quantification of Dolutegravir Using Ultra Performance Liquid Chromatography Coupled With UV DetectionXinzhu Wang, Sujan Dilly Penchala, Alieu Amara, et al.Therapeutic Drug Monitoring|May 17, 2014
CYP2B6 516G>T (rs3745274) and smoking status are associated with efavirenz plasma concentration in a Serbian cohort of HIV patientsAdeniyi Olagunju, Marco Siccardi, Alieu Amara, et al.Biomedical Chromatography : BMC|October 20, 2019
The development and validation of a novel LC-MS/MS method for the quantification of cenicriviroc in human plasma and cerebrospinal fluidSujan Dilly Penchala, Jasmini Alagaratnam, Elizabeth Challenger, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|June 27, 2017
Development, validation and clinical application of a method for the simultaneous quantification of lamivudine, emtricitabine and tenofovir in dried blood and dried breast milk spots using LC-MS/MSCatriona Waitt, Sujan Diliiy Penchala, Adeniyi Olagunju, et al.Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 17, 2023
Undeclared pre-exposure or post-exposure prophylaxis (PrEP/PEP) use among syphilis-positive blood donors, England, 2020 to 2021Victoria Maddox, Claire Reynolds, Alieu Amara, et al.Antimicrobial Agents and Chemotherapy|February 10, 2016
Removal of Dolutegravir by Hemodialysis in HIV-Infected Patients with End-Stage Renal DiseaseJosé Moltó, Fredzzia Graterol, Cristina Miranda, et al.Antimicrobial Agents and Chemotherapy|June 29, 2011
Pharmacokinetics of once-daily darunavir-ritonavir and atazanavir-ritonavir over 72 hours following drug cessationMarta Boffito, Akil Jackson, Alieu Amara, et al.The Journal of Antimicrobial Chemotherapy|December 19, 2015
Dolutegravir and elvitegravir plasma concentrations following cessation of drug intakeEmilie Elliot, Alieu Amara, Akil Jackson, et al.The Journal of Antimicrobial Chemotherapy|October 2, 2018
Pharmacokinetics of dolutegravir with and without darunavir/cobicistat in healthy volunteersEmilie R Elliot, Maddalena Cerrone, Elizabeth Challenger, et al.Pageof 4